Show simple item record

Amygdaloid Kindling and the GABA System

dc.contributor.authorMyslobodsky, Michael S.en_US
dc.contributor.authorValenstein, Elliot S.en_US
dc.date.accessioned2010-04-01T15:37:29Z
dc.date.available2010-04-01T15:37:29Z
dc.date.issued1980-04en_US
dc.identifier.citationMyslobodsky, Michael S.; Valenstein, Elliot S. (1980). "Amygdaloid Kindling and the GABA System." Epilepsia 21(2): 163-175. <http://hdl.handle.net/2027.42/66112>en_US
dc.identifier.issn0013-9580en_US
dc.identifier.issn1528-1167en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/66112
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7358042&dopt=citationen_US
dc.description.abstractThe effect of increased brain GABA levels on fully kindled amygdala seizures was investigated in Long-Evans rats. The newly synthesized GABA-transaminase inhibitor, -Γ-acetylenic GABA (GAG) administered on four consecutive days (100 mg/kg, followed by 50 mg/kg, i.p.) was found to either significantly reduce, or eliminate entirely, the behavioral seizures normally produced by amygdala stimulation. The effect is seen after the first injection of GAG although its magnitude was greater on subsequent days. Behavioral seizures reappeared 2 to 3 days after termination of GAG treatment. The duration of electrographic seizures (self-sustained amygdala after-discharge) was either unchanged or greater on the first day of GAG treatment, but was briefer on subsequent days. The duration of afterdischarges returned to normal levels 1 to 2 days earlier than the behavioral seizures after the termination of GAG. Picrotoxin (1.5-2 mg/kg, i.p.) did not antagonize either electrographic or behavioral effects of inhibition produced with GAG. Electrical stimulation of amygdala delivered during the initial sedation stage induced by picrotoxin resulted in further regression of kindled seizures in the majority of animals. Although in doses employed, GAG alleviates amygdaloid-kindled seizures its use requires caution in view of its ability to reduce arousal level. RÉSUMÉ L'effet de l'ÉlÉvation des taux cÉrÉbraux de GABA sur les crises amygdaliennes par effet d'embrasement complet a ÉtÉÉtudiÉ chez des rats Long-Evans. l'injection pendant 4 jours consÉcutifs de 100 mg/kg suivis de 50 mg/kg i.p. d'un inhibiteur de la GABA. Transaminase nouvellement synthÉtisÉ (Γ-acetylenic GABA ou GAG) a significativement rÉduit ou mÊme supprimÉ les crises normalement provoquÉes par la stimulation amygdalienne. l'effet est observÉ aprÈs la premiere injection de GAG, mais son importance s'accroit les jours suivants. Les crises rÉapparaissent 2 ou 3 jours aprÈs la fin du traitement au GAG. Du point de vue Électrographique, la durÉe de la postdÉcharge amygdalienne autoentretenue est inchingÉe ou accrue le premier jour du traitement, mais elle diminue les jours suivants pour retourner À la normale un ou deux jours avant que les crises ne rÉapparaissent aprÈs la fin de ('administration du GAG. l'injection de picrotoxine (1.5-2 mg/kg i.p.) ne s'oppose pas aux effets inhibiteurs du GAG sur les crises ou leur accompagnement EEG. La stimulation Électrique de l'amygdala pendant l'Étape sÉdative initiate induite par la picrotoxine provoque une rÉgression supplÉmentaire des crises d'embrasement chez la majoritÉ des animaux. Bien que, aux doses utilisÉes, le GAG attÉnue les crises amyg-daliennes d'embrasement, son utilisation nÉcessite des prÉcautions compte tenu de sa tendance À rÉduire le niveau d'Éveil. RESUMEN En ratas Long-Evans se ha investigado el efecto del aumento de los niveles cerebrales de GABA, sobre los ataques originados en la amÍgdala totalmente condicionada, (Kindling). El recientemente sintetizado in-hibidor de la GABA transaminasa, Γ-acetilÉnico GABA (GAG), redujo significativamente o eliminÓ totalmente las crisis de comportamiento que habitualmente se producen con la estimulaciÓn de la amÍgdala. El efecto se observa despuÉs de la primera in-yecciÓn de GAG pero su magnitud aumentÓ en dias subsiguientes. Las crisis de comportamiento reaparecieron a los 2–3 dÍas de la interrupciÓn del tratamiento con GAG. La duraciÓn de los ataques electrogrÁficos (perservaciÓn de la post-descarga de la amigdala) no se modificÓ, o incluso aumentÓ, en el primer dia de la administraciÓn de GAG pero se redujo en los dias siguientes. La duraciÓn de las post-descargas volviÓ a sus niveles normales 1 o 2 dias antes que la reapariciÓn de las crisis de comportamiento una vez terminado el tratamiento con GAG. La picrotoxina (1.5-2 mg/kg, i.p.) no antagonizÓ los efectos inhibitorios producidos por el GAG sobre el electroencefalograma o las crisis de comportamiento. La estimulaciÓn elÉctrica sobre la amÍgdala, aplicada durante la fase de sedaciÓn inicial inducida por la picrotoxina, condujo a una regresiÓn aÚn mÁs intensa de las crisis condicionadas, en la mayorÍa de los animales. A pesar de que, con las dosis utilizadas, el GAG alivia las crisis de la amÍgdala previamente condicionada, se requiere gran precauciÓn en su utilizaciÓn en vista de su propiedad de reducir el nivel del despertar. ZUSAMMENFASSUNG Die Wirkung erhÖhter GABA-Spiegel des Gehirns auf AmygdalonkrÄmpfe nach Kindling wurden bei Long-Evans-Ratten untersucht. Der neuerdings synthetisierte GABA-TYansaminasen-Inhibitor, Gamma-Acetylen-GABA (GAG) wurde an 4 aufeinander-folgenden Tagen in einer Dosis von 100 mg/kg und anschlieliend 50 mg/kg i.p. verabfolgt. Er reduzierte entweder signifikant oder eliminierte vÖllig die anfalls-weisen VerhaltensÄnderungen, die normalerweise durch Stimulation des Amygdalon produziert wurden. Die Wirkung ist nach der Erstinjektion des GAG zu beobachten, obgleich ihr Ausmaß an folgenden Tagen grÖßer war. Die VerhaltensanfÄlle kamen 2 bis 3 Tagen nach Beendigung der GAG-Behandlung wieder. Die Dauer der elektrographischen AnfÄlle (sich selbst un-terhaltende Amydalonnachentladungen) blieben entweder gleich oder sie wurden grÖßer am 1. Tag der GAG-Behandlung, wurden aber kÜrzer an folgenden Tagen. Die Dauer der Nachentladungen nor-malisierte sich 1 bis 2 Tage frÜher als die VerhaltensanfÄlle nach Beendigung des GAG verschwanden. Picrotoxin (1.5 bis 2 mg/kg i.p.) wirken nicht als Antagonist gegenÜber der durch GAG produzierten Hemmung der elektrographischen-oder Verhalten-seffekte. Die elektrische Stimulierung des Amygdalon wÄhrend der initialen Sedierung nach Picrotoxin ver-ursachte bei der Mehrzahl der Tiere einen weiteren RÜckgang der durch Kindling entstandenen AnfÄlle. Obgleich das GAG in den verwandten Dosen, die durch Kindling des Amygdalon erzeugten KrÄmpfe leichter ablaufen lUßt, erfordert seine Anwendung Vorsicht hinsichtlich seiner FÄhigkeit, das Erreg-barkeitsniveau zu senken.en_US
dc.format.extent1640633 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1980 International League Against Epilepsyen_US
dc.subject.otherAmygdalaen_US
dc.subject.otherKindlingen_US
dc.subject.otherGABAen_US
dc.subject.otherPicrotoxinen_US
dc.subject.otherGAGen_US
dc.subject.otherSeizuresen_US
dc.titleAmygdaloid Kindling and the GABA Systemen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Psychology and Neuroscience Laboratory, University of Michigan, Ann Arbor, Michigan 48109en_US
dc.identifier.pmid7358042en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/66112/1/j.1528-1157.1980.tb04058.x.pdf
dc.identifier.doi10.1111/j.1528-1157.1980.tb04058.xen_US
dc.identifier.sourceEpilepsiaen_US
dc.identifier.citedreferenceAnden NE Dalen, and Johansson B. Baclofen and lithium in Huntington's Chorea. Lancet 2 : 93, 1973.en_US
dc.identifier.citedreferenceAndersen P and Andersson SA. Physiological Basis of Alpha-Rhythm. Appleton-Century-Crofts, New York, 1968.en_US
dc.identifier.citedreferenceBabington RG and Wedeking PW. The pharmacology of seizures induced by sensitization with low intensity brain stimulation. Pharmacol Biochem Behav 1 : 461 – 467, 1973.en_US
dc.identifier.citedreferenceBall GJ, Gloor P, and Schane N. The cortical elec-tromicrophysiology of pathological delta waves in the electroencephalogram of cats. Elect roen-cephalogr Clin Neurophysiol 43 : 346 – 361, 1977.en_US
dc.identifier.citedreferenceBiswas B and Carlsson A. The effect of intracere-broventricularly administered GABA on brain monoamine metabolism. Nannyn Schmiedeberg's Arch Pharmacol 299 : 41 – 46, 1977a.en_US
dc.identifier.citedreferenceBiswas B and Carlsson A. The effect of intraperitone-ally administered GABA on brain monoamine metabolism. Naunyn Schmiedeberg's Arch Pharmacol 299 : 47 – 51, 1977b.en_US
dc.identifier.citedreferenceBowery NG and Dray A. Barbiturate reversal of amino acid antagonism produced by convulsant agents. Nature 264 : 276 – 278, 1976.en_US
dc.identifier.citedreferenceBuckwald NA, Hull CD, Trachtenberg MC. Concomitant behavioral and neural inhibition and disinhi-bition in response to subcortical stimulation. Exp. Brain Res 4 : 58 – 72, 1967.en_US
dc.identifier.citedreferenceCarlidge NE, Hudgson P, and Weightman D. A comparison of baclofen and diazepam in the treatment of spasticity. J Neurol Sci 23 : 17 – 24, 1974.en_US
dc.identifier.citedreferenceCooper BR, Viik K, Ferris' RM, and White HL. Antagonism of the enhanced susceptibility to audiogenic seizures during alcohol withdrawal in the rat by Γinobutyric acid (GABA) and “GABA-mimetic” agents. J Pharmacol Exp Ther 209 : 396 – 403, 1979.en_US
dc.identifier.citedreferenceCorcoran ME, Fibiger HC, McCaughran JA, and Wada JA. Potentiation of amygdaloid kindling and metrazol-induced seizures by 6-hydroxydopamine in rats. Exp Neurol 45 : 118 – 133, 1974.en_US
dc.identifier.citedreferenceCosta E. Some recent advances in the biochemical pharmacology of y-aminobutyric acid. In : Usdin E, Hamburg DA and Barchas JD ( Eds ), Neuroregulators and Psychiatric Disorders, Oxford University Press, New York, 1977, pp. 372 – 378.en_US
dc.identifier.citedreferenceEngel J and Katzman R. Facilitation of amygdaloid kindling by lesions of the stria terminalis. Brain Res 122 : 137 – 142, 1977.en_US
dc.identifier.citedreferenceFallon JH, Koziell DA, and Moore RY. Catecholamine innervation of the basal ganglia. II. Amygdala, suprarhinal cortex and autorhovel cortex. J Comp Neurol 80 : 509 – 532, 1978.en_US
dc.identifier.citedreferenceFariello R. Forebrain influences on the amygdaloid acute focus in the cat. Exp Neurol 51 : 515 – 528, 1976.en_US
dc.identifier.citedreferenceFeldman RG, Kelly-Hayes M, Conomy JP, and Foley JM. Baclofen for spasticity in multiple sclerosis. Neurology 28 : 1094 – 1098, 1978.en_US
dc.identifier.citedreferenceGoddard GV. Development of epileptic seizures through brain stimulation at low intensity. Nature 214 : 1020, 1967.en_US
dc.identifier.citedreferenceGoddard GV and Douglas RM. Does the engram of kindling model the engram of normal long term memory. Can J Neurol 2 : 385 – 394, 1975.en_US
dc.identifier.citedreferenceGuselnikov VI and Supin AY. Rhythmical Activity of the Brain. Moscow University Press, Moscow, 1968.en_US
dc.identifier.citedreferenceJung MJ, Lippert B, Metcalf BW, Schechter PJ, Bohlen P, and Sjoerdsma A. The effect of 4-amino Hex-5-ynoic acid (x-acetylenic GABA, y-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo. J Neurochem 28 : 717 – 723, 1977a.en_US
dc.identifier.citedreferenceJung MJ, Lippert B, Metcalf BW, BÖhlen P, and Schechter PJ. Γ-Vinyl-GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: Effects on brain GABA metabolism in mice. J Neurochem 29 : 797 – 802, 1977b.en_US
dc.identifier.citedreferenceKrnjevi K. Effects of drugs on inhibitory synapses. In : Advances in Cytopharmacology, Vol. I. In : Dementi B and Ceccarelli B ( eds. ) First International Symposium on Cell Biology and Cytopharmacology. Raven Press, New York, 1971, pp. 419 – 426.en_US
dc.identifier.citedreferenceKrnjevi K. Chemical nature of synaptic transmission in vertebrates. Physiol Rev 54 : 418 – 540, 1974.en_US
dc.identifier.citedreferenceKupfermann I. Modulatory actions of neurotransmitters. Am Rev Neurosci 2 : 447 – 465, 1979.en_US
dc.identifier.citedreferenceLa Grutta V, Amato G, and Zagam MT. The importance of the caudate nucleus in the control of convulsive activity in the amygdaloid complex, and temporal cortex in the cat. Electroencephalogr Clin Neurophysiol 31 : 57 – 69, 1971.en_US
dc.identifier.citedreferenceLe Salle G, Paxinos G, Emson P, and Ben-Ari Y. Neurochemical mapping of GABAergic systems in the amygdaloid complex and bed nucleus of the stria terminalis. Brain Res 155 : 397 – 403, 1978.en_US
dc.identifier.citedreferenceLevy RA. The role of GABA in primary afferent de-polarisation. Prog Neurobiol 9 : 211 – 267, 1977.en_US
dc.identifier.citedreferenceMaynert EW, Marczynski TJ, and Browning RA. The role of the neurotransmitters in the epilepsies. In : Friedlander WJ ( Ed ) Advances in Neurology, Raven Press, New York, 1975, pp. 79 – 147.en_US
dc.identifier.citedreferenceMcGeer PL, Eccles Sir JC, and McGeer EG. Molecular Neurobiology of the Mammalian Brain. Plenum Press, New York, 1978.en_US
dc.identifier.citedreferenceMeldrum BS. Epilepsy and GABA-mediated inhibition. Int Rev Neurobiol 17 : 1 – 36, 1975.en_US
dc.identifier.citedreferenceMeldrum B and Horton R. Blockade of epileptic responses in the photosensitive baboon, papio papio, by two irreversible inhibitors of GABA-transami-nase, Γ-acetylenic GABA (4-amino-hex-5-ynoic acid) and Γ-vinyl GABA (4-amino-hexeno acid). Psychopharmacology 59 : 47 – 50, 1978.en_US
dc.identifier.citedreferenceMyslobodsky M. Petit Mai Epilepsy: A Search for Precursors of Wave-spike Discharges. Academic Press, New York, 1976.en_US
dc.identifier.citedreferenceMyslobodsky MS, Ackermann RF, and Engel J. Effects of Γ-acetylenic GABA and -Γ-vinyl GABA on metrazol-activated, and kindled seizures. Pharmacol Biochem Behav 11 : 265 – 271, 1979.en_US
dc.identifier.citedreferenceNicoll RA. Phentobarbital: Differential postsynaptic action on sympathetic ganglion cells. Science 199 : 451 – 452, 1978.en_US
dc.identifier.citedreferencePalfreyman MG, Huot S, Lippert B, and Schechter PJ. The effect of Γ-acetylenic GABA, an enzyme-activated irreversible inhibitor of GABA-transaminase on dopamine pathways of the extrapyramidal and limbic systems. Eur J Pharmacol 50 : 325 – 336, 1978.en_US
dc.identifier.citedreferencePurpura DP, McMurtry JG, and Maekawa K. Synaptic events in ventrolateral thalamic neurons during suppression of recruiting responses by brain stem reticular stimulation. Brain Res 1 : 63 – 76, 1966.en_US
dc.identifier.citedreferenceRacine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32 : 281 – 294, 1972.en_US
dc.identifier.citedreferenceRansom BR and Baker JL. Phenobarbital selectively enhances GABA-mediated postsynaptic inhibition in tissue cultured mouse spinal neurons. Brain Res 114 : 130 – 135, 1976.en_US
dc.identifier.citedreferenceRoberts E, Kuriyama K, and Haber B. Biochemistry of synaptic inhibition at the cellular level: The GABA system. In : Costa E and Giacobini E ( Eds ), Advances in Biochemical Psychopharmacology, Raven Press, New York, 1970, pp. 131 – 167.en_US
dc.identifier.citedreferenceRoberts E and Simonsen DG. A hypnotic and possible analgesic effect of imidazoleacetic acid in mice. Biochem Pharmacol 15 : 1875 – 1877, 1966.en_US
dc.identifier.citedreferenceSato M and Nakashima T. Kindling: Secondary epileptogenesis, sleep and catecholamines. Can J Neurol Sci 2 : 434 – 446, 1975.en_US
dc.identifier.citedreferenceSchechter PJ, Tranier Y, Jung MJ, and BÖhlen P. Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of Γ-acetylenic GABA and -Γ-vinyl GABA, two irreversible GABA-T inhibitors. Eur J Pharmacol 45 : 319 – 328, 1977a.en_US
dc.identifier.citedreferenceSchechter PJ, Tranier Y, Jung MJ, and Sjoerdsma A. Antiseizure activity of Γ-acetylenic Γ-aminobutyric acid: A catalytic irreversible inhibitor of Γ-aminobutyric acid transaminase. J Pharmacol Exp Ther 201 : 606 – 612, 1977b.en_US
dc.identifier.citedreferenceScotti de Carolis A and Massotti M. Electroencepha-lographic and behavioral investigations on “gabaergic” drugs muscimol, baclofen and sodium Γ-hydroxybutyrate. Prog Neuropsvchopharmacol 2 : 431 – 442, 1978.en_US
dc.identifier.citedreferenceSkrebitsky VG. Inhibition of inhibitory postsynaptic components of the visual evoked potentials during auditory stimulus presentation. Z Viss Nerun Dejat 17 : 158 – 168, 1967.en_US
dc.identifier.citedreferenceTanaka T, Lange H, and Naquet R. Sleep, Subcortical stimulation and kindling in the cat. Can J Neurol Sci 2 : 447 – 455, 1975.en_US
dc.identifier.citedreferenceValenstein ES and Myslobodsky MS. An inability of Γ-acetylenic GABA and picrotoxin to block eating evoked by hypothalamic stimulation. Submitted..en_US
dc.identifier.citedreferenceWada JA. Pharmacological prophylaxis in the kindling model of epilepsy. Arch Neurol 34 : 389 – 395, 1977.en_US
dc.identifier.citedreferenceWada JA and Sato M. Generalized convulsive seizures induced by daily electrical stimulation of the amygdala in cats. Neurol (Minn.) 24 : 565 – 574, 1974.en_US
dc.identifier.citedreferenceWang JC and Ward JW. Analeptics. Pharmacol Ther Bull 3 : 123 – 165, 1977.en_US
dc.identifier.citedreferenceWise RA and Chinerman J. Effects of diazepam and phenobarbital on electrically-induced amygdaloid seizures and seizure development. Exp Neurol 45 : 355 – 363, 1974.en_US
dc.identifier.citedreferenceWood JD, Durham JS, and Peesker SJ. Effect of di-n- propylacetate and Γ-acetylenic GABA on hyperbaric oxygen-induced seizures and GABA metabolism. Neurochem Res 2 : 707 – 715, 1977.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.